Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|December 18, 2023
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosisMarta Tonon, Roberta D'Ambrosio, Valeria Calvino, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antiviralsSerena Pelusi, Cristiana Bianco, Massimo Colombo, et al.
International Journal of Molecular Sciences|April 30, 2014
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependentRoberta D'Ambrosio, Alessio Aghemo, Raffaele De Francesco, et al.
Antiviral Therapy|August 6, 2011
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapyRoberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.
The Journal of Infectious Diseases|September 13, 2023
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in ItalyLoreta A Kondili, Lucia Craxì, Felice Nava, et al.
Plos One|August 30, 2014
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis CStella De Nicola, Paola Dongiovanni, Alessio Aghemo, et al.
Development (Cambridge, England)|September 13, 2017
Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitorsFilippo Casoni, Laura Croci, Camilla Bosone, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2023
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre studyNicola Pugliese, Vincenza Calvaruso, Mario Masarone, et al.
Pageof 11